Students and staff must be fully vaccinated by the start of the fall semester, submit to weekly COVID-19 testing and wear masks indoors throughout campus.
INDIA New England News
Bruce Walker
BOSTON- As part of the 7th of July fundraiser to support Vax.India.Now, the Anuradha Palakurthi Foundation will host a panel of experts to share experiences on the rollout of coronavirus vaccines in the U.S. The group includes:
–
–
–
–
–
Chris Caplice, Executive Director of the MIT’s Center for Transportation & Logistics.
Among the topics discussed will be vaccine efficacy and effective supply chain strategies for rapid vaccine rollout; balancing societal needs; modeling for herd immunity; and strategies for reopening universities, businesses, and society.
Mr.
Anuradha Palakurthi Photo: Facebook)
Said Anuradha Juju Palakurthi “The slow return to normalcy in the USA was a path of thoughtful and smart plans. As always when the rubber meets the road these plans had to be re-thought. India’s deployment plans can benefit by evaluating the relevancy of these experiences. The VaxIndiaNow event is grateful to
Faculty members discussed MIT’s Diversity, Equity, and Inclusion (DEI) Strategic Action Plan, issues surrounding MIT’s relations with China and international research collaborations, and updates on vaccine roll-out at the Feb. 17 faculty meeting.
Associate Provost Tim Jamison, Institute Community and Equity Officer (ICEO) John Dozier, and Deputy ICEO Maryanne Kirkbride presented updates on MIT’s development of a strategic action plan for DEI. Those involved with developing the plan include the DEI steering team which includes the Institute’s Committee on Race and Diversity.
An estimated timeline for the strategic plan presented to faculty projects that a first draft of the plan will be available in March and a second draft in April. Both drafts will receive community engagement before a final draft is developed in May, as well as an implementation plan and a public launch of the strategic action plan.
Credits: Photo: Dave Tytell
Next image
The Commonwealth of Massachusetts has approved MIT’s request to serve as an employer-based distributor of the Covid-19 vaccine.
The designation means that as sufficient doses of the vaccine become available over the coming months, the Institute will be in a position to vaccinate some 50,000 MIT students, employees, affiliates, and their dependents regardless of whether MIT Medical is their primary care provider.
MIT brings to this effort its long track record running one of the largest flu vaccination clinics in New England, as well as its recent experience administering regular Covid-19 tests to thousands of members of the MIT community. This expertise will allow MIT Medical to help relieve pressure on local hospitals, health systems, medical offices, and other entities that are expected to play a leading role in vaccinating millions of residents of the Boston area.